Table 1.
Serum concentrations of CCL20 and AFP.
| Markers | Control group |
Benign disease group |
HCC group |
Stage I |
Stage II |
Stage III |
Stage IV |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Median | IQR | Median | IQR | Median | IQR | Median | IQR | Median | IQR | Median | IQR | Median | IQR | |
| CCL20 | 7.57 | 1.45–34.67 | 17.10 | 7.71–70.38 | 33.80 | 3.86–615.68 | 26.87 | 10.47–103.50 | 18.73 | 8.15–132.17 | 31.3 | 24.24–119.10 | 57.15 | 22.74–174.63 |
| AFP | 2.50 | 1.98–3 | 2.70 | 2.10–5.70 | 352.15 | 13.18–3000 | 49.70 | 10.05–3000 | 629.00 | 12.8–3000 | 1168.8 | 44.68–3000 | 98.5 | 8.61–1563.6 |